工程化免疫:CAR-T 细胞治疗的当前进展与未来方向
Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy.
61.1分
★★★☆☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy.
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。